Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
10 Feb, 2022
Montagu-owned Arkopharma, a French manufacturer of natural health products, is up for sale, according to market sources.
The sell-side adviser has yet to be decided, sources added. The company will be marketed at roughly €40 million EBITDA.
Another firm in the same sector — Havea — is also up for sale, with Natixis Partners advising; sources suggest interest parties may wait to see how the Havea deal goes first before committing to Arkopharma.
Arkopharma is a pharmaceutical laboratory business specializing in the field of phytotherapy.